Posts

Showing posts with the label Ranitidine

Future Prospects of Global Laboratory Proficiency Testing Market

Image
Laboratory Proficiency Testing Market  The global Laboratory Proficiency Testing Market is estimated to be valued at US$ 1.29 billion in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 - 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Laboratory proficiency testing involves evaluating the performance of laboratories for a given scope of testing through inter-laboratory comparisons. It helps assess the quality and competence of laboratories by determining reproducibility and accuracy of test results. Proficiency testing products are used by laboratories to determine method validity and accuracy, and improve testing processes. Market Key Trends: One of the major trends in the laboratory proficiency testing market is the growing number of accredited medical laboratories. Accreditation assures compliance with ISO 15189 and ISO/IEC 17025 standards, which require participation in proficiency testing programs. Acc...

Ranitidine Market Size, Share, Trends, and Forecast till 2026

Image
  Ranitidine Market Due to the rising prevalence of gastroesophageal reflux disease (GERD) and stomach and intestinal ulcers, healthcare experts have taken a strong interest in their treatment. GERD is a frequent health disease that can result in major medical consequences as well as a significant financial outlay for diagnosis and treatment. Heartburn and acid regurgitation are the two most common symptoms associated with GERD. To reduce the effects of stomach acids or stop acid production, over-the-counter antacids, proton pump inhibitors, and H-2 receptor blockers are commonly utilised. Ranitidine is a histamine H2 antagonist that is used to treat gastroesophageal reflux disease. It is available as an over-the-counter (OTC) and prescription medicine (GERD). For up to 12 hours, ranitidine reduces stomach acid production. Erosive esophagitis, peptide ulcer disease, and Zollinger–Ellison syndrome are all treated with ranitidine. It can be administered either orally or intravenous...

Ranitidine Market analysis and Growing Research and Development (R&D) on Ranitidine

Image
The treatment of gastroesophageal reflux disease (GERD) and stomach and intestinal ulcers has piqued the interest of healthcare professionals, owing to the growing prevalence of these conditions. GERD is a frequent health issue that can result in major medical consequences as well as a significant financial outlay for diagnosis and treatment. Heartburn and acid regurgitation are the two most commonly observed symptoms of GERD. To reduce the effects of stomach acids or to stop acid production, over-the-counter antacids, proton pump inhibitors, and H-2 receptor blockers are commonly utilised. Ranitidine is a histamine H2 antagonist that is used to treat gastroesophageal reflux disease. It is available as an over-the-counter (OTC) and prescription medicine (GERD). For up to 12 hours, ranitidine reduces stomach acid production. Erosive esophagitis, peptide ulcer disease, and Zollinger–Ellison syndrome are all treated with ranitidine. It can be administered either orally or intravenously....

Popular posts from this blog

Future Prospects of Global Laboratory Proficiency Testing Market

Malaria Vaccines Market – Making Way for a Malaria-Free World

Global and China Catheter Market Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027